Variables | Disease-free survival | |||
---|---|---|---|---|
Univariate | Multivariate | |||
HR (95%CI) | P value | HR (95%CI) | P value | |
Age (>60 vs. ≤60, years) | 1.370 (0.846-2.218) | 0.200 | 1.516 (0.934-2.460) | 0.092 |
Gender (male vs. female) | 1.397 (0.854-2.283) | 0.183 | Â | Â |
Preoperative CEA (>5 vs. ≤5, ng/ml) | 1.600 (0.990-2.584) | 0.055 |  |  |
Preoperative CA19-9 (>37 vs. ≤37, U/ml) | 2.268 (1.362-3.778) | 0.002 | 1.821 (1.066-3.112) | 0.028 |
Diabetes | 0.746 (0.357-1.562) | 0.437 | Â | Â |
Hypertension | 1.303 (0.787-2.158) | 0.303 | Â | Â |
Tumor location (ileocecal /ascending colon vs. hepatic flexure colon) | 1.400 (0.862-2.276) | 0.174 | Â | Â |
Operative time (min) | 1.002 (0.997-1.007) | 0.389 | Â | Â |
Estimated blood loss (ml) | 0.997 (0.992-1.001) | 0.181 | Â | Â |
pT stage (T3/4 vs. T1/2) | 5.493 (0.762-39.579) | 0.091 | 3.416(0.447-26.102) | 0.236 |
pN stage (N+ vs. N0) | 3.021 (1.814-5.032) | <0.001 | 2.373 (1.219-4.662) | 0.011 |
Tumor differentiation (grade 3+4 vs. 1+2) | 1.954 (0.933-4.089) | 0.076 | Â | Â |
Histopathology (mucinous/signet ring cell adenocarcinoma vs. adenocarcinoma) | 1.257 (0.763-2.071) | 0.370 | Â | Â |
Lymphovascular invasion | 2.689 (1.550-4.665) | <0.001 | 2.271 (1.289-4.001) | 0.005 |
Nerval invasion | 1.603 (0.818-3.142) | 0.169 | Â | Â |
Postoperative complications | 0.822 (0.463-1.460) | 0.503 | Â | Â |
Adjuvant chemotherapy | 2.625 (1.375-5.010) | 0.003 | 0.912 (0.383-2.170) | 0.835 |
ALI (low vs. high) | 2.286 (1.372-3.806) | 0.001 | 2.389 (1.434-3.982) | 0.001 |